{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T12:59:36Z","timestamp":1791377976251,"version":"4.3.2"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T00:00:00Z","timestamp":1775347200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006364","name":"INCa","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007391","name":"Association pour la Recherche sur le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007391","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004097","name":"Fondation ARC pour la Recherche sur Le Cancer","doi-asserted-by":"publisher","award":["ARCSIGNIT2023020006228"],"award-info":[{"award-number":["ARCSIGNIT2023020006228"]}],"id":[{"id":"10.13039\/501100004097","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ejca.2026.116731","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T01:15:57Z","timestamp":1775438157000},"page":"116731","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["From clusters to clinic: An 8-gene signature combined with mucinous component stratifies benefit of anti-CTLA-4 addition to anti-PD-1 in dMMR\/MSI-H metastatic colorectal cancer"],"prefix":"10.1016","volume":"239","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4131-2409","authenticated-orcid":false,"given":"Margherita","family":"Ambrosini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Gallois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2873-5108","authenticated-orcid":false,"given":"Annalice","family":"Gandini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Lecanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Alouani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Pietrantonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Bergamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Cremolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibault","family":"Mazard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8065-9635","authenticated-orcid":false,"given":"David","family":"Tougeron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosine","family":"Guimbaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7593-8138","authenticated-orcid":false,"given":"Sara","family":"Lonardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janick","family":"Selves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8950-1949","authenticated-orcid":false,"given":"Sophie","family":"Mouillet-Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6073-4466","authenticated-orcid":false,"given":"Jean-Francois","family":"Emile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Taieb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8475-5459","authenticated-orcid":false,"given":"Pierre","family":"Laurent-Puig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2026.116731_bib1","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0140-6736(24)02848-4","article-title":"Nivolumab plus ipilimumab versus nivolumab in microsatellite instability-high metastatic colorectal cancer (CheckMate 8HW): a randomised, open-label, phase 3 trial","volume":"405","author":"Andr\u00e9","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.ejca.2026.116731_bib2","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.annonc.2024.11.012","article-title":"Pembrolizumab versus chemotherapy in microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer: 5-year follow-up from the randomized phase III KEYNOTE-177 study","volume":"36","author":"Andr\u00e9","year":"2025","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2026.116731_bib3","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ejca.2022.05.044","article-title":"Prognostic impact of performance status on the outcomes of immune checkpoint inhibition strategies in patients with dMMR\/MSI-H metastatic colorectal cancer","volume":"172","author":"Mazzoli","year":"2022","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2026.116731_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2025.115645","article-title":"Prognostic impact of the BRAF V600E mutation in patients with MSI-high metastatic colorectal cancer treated with immune checkpoint inhibitors","volume":"227","author":"Gallois","year":"2025","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2026.116731_bib5","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/s41416-023-02524-3","article-title":"Primary resistance to immunotherapy in patients with a dMMR\/MSI metastatic gastrointestinal cancer: who is at risk? An AGEO real-world study","volume":"130","author":"Flecchia","year":"2024","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejca.2026.116731_bib6","first-page":"500","article-title":"Microsatellite instable vs stable colon carcinomas: analysis of tumour heterogeneity, inflammation and angiogenesis","volume":"113","author":"De Smedt","year":"2015"},{"key":"10.1016\/j.ejca.2026.116731_bib7","doi-asserted-by":"crossref","first-page":"8868","DOI":"10.1038\/s41467-025-63960-8","article-title":"Inflammation and mutational burden differentially associated with nivolumab or ipilimumab combination efficacy in colorectal cancer","volume":"16","author":"Lei","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.ejca.2026.116731_bib8","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1158\/1078-0432.CCR-22-3964","article-title":"Transcriptomic signatures of MSI-high metastatic colorectal cancer predict efficacy of immune checkpoint inhibitors","volume":"29","author":"Gallois","year":"2023","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2026.116731_bib9","first-page":"1351","article-title":"Clinicopathological, Molecular Features and Prognosis of Colorectal Cancer with Mucinous Component","volume":"17","author":"Li","year":"2021"},{"key":"10.1016\/j.ejca.2026.116731_bib10","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/modpathol.2017.18","article-title":"Mapping clinicopathological entities within colorectal mucinous adenocarcinomas: a hierarchical clustering approach","volume":"30","author":"Liddell","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ejca.2026.116731_bib11","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1093\/bioinformatics\/bti631","article-title":"Simple decision rules for classifying human cancers from gene expression profiles","volume":"21","author":"Tan","year":"2005","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ejca.2026.116731_bib12","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/bioinformatics\/btu622","article-title":"switchBox: an R package for k-Top Scoring Pairs classifier development","volume":"31","author":"Afsari","year":"2015","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ejca.2026.116731_bib13","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1186\/1471-2105-12-375","article-title":"Top scoring pairs for feature selection in machine learning and applications to cancer outcome prediction","volume":"12","author":"Shi","year":"2011","journal-title":"BMC Bioinforma"},{"key":"10.1016\/j.ejca.2026.116731_bib14","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1186\/1471-2164-14-336","article-title":"A simple and reproducible breast cancer prognostic test","volume":"14","author":"Marchionni","year":"2013","journal-title":"BMC Genom"},{"key":"10.1016\/j.ejca.2026.116731_bib15","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1093\/bioinformatics\/btab763","article-title":"A comparison of rule-based and centroid single-sample multiclass predictors for transcriptomic classification","volume":"38","author":"Eriksson","year":"2022","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ejca.2026.116731_bib16","doi-asserted-by":"crossref","first-page":"7625","DOI":"10.1038\/s41467-025-62976-4","article-title":"H2A.Z primes an epigenetic landscape for memory CD8+ T cell recall response","volume":"16","author":"Liang","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.ejca.2026.116731_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/pro.4859","article-title":"Dynamic proximity interaction profiling suggests that YPEL2 is involved in cellular stress surveillance","volume":"33","author":"Turan","year":"2024","journal-title":"Protein Sci"},{"key":"10.1016\/j.ejca.2026.116731_bib18","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13072-019-0274-9","article-title":"The histone variant H2A.Z in gene regulation","volume":"12","author":"Giaimo","year":"2019","journal-title":"Epigenetics & Chromatin"},{"key":"10.1016\/j.ejca.2026.116731_bib19","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1677\/JME-08-0156","article-title":"Hexose-6-phosphate dehydrogenase: linking endocrinology and metabolism in the endoplasmic reticulum","volume":"42","author":"B\u00e1nhegyi","year":"2009","journal-title":"J Mol Endocrinol"},{"key":"10.1016\/j.ejca.2026.116731_bib20","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jsbmb.2013.02.002","article-title":"Changing glucocorticoid action: 11\u03b2-hydroxysteroid dehydrogenase type 1 in acute and chronic inflammation","volume":"137","author":"Chapman","year":"2013","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.ejca.2026.116731_bib21","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.cmet.2017.05.007","article-title":"Cytochrome c Oxidase Activity Is a Metabolic Checkpoint that Regulates Cell Fate Decisions During T Cell Activation and Differentiation","volume":"25","author":"Tarasenko","year":"2017","journal-title":"Cell Metab"},{"key":"10.1016\/j.ejca.2026.116731_bib22","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.4049\/jimmunol.2000612","article-title":"Dynamic Roles for IL-2-STAT5 Signaling in Effector and Regulatory CD4+ T Cell Populations","volume":"205","author":"Jones","year":"2020","journal-title":"J Immunol"},{"key":"10.1016\/j.ejca.2026.116731_bib23","article-title":"Interleukin-2 and STAT5 in regulatory T cell development and function","volume":"2","author":"Mahmud","year":"2013"},{"key":"10.1016\/j.ejca.2026.116731_bib24","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41419-022-05470-9","article-title":"Non-canonical functions of spliceosome components in cancer progression","volume":"14","author":"Ivanova","year":"2023","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.ejca.2026.116731_bib25","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s13238-021-00856-5","article-title":"Emerging roles of spliceosome in cancer and immunity","volume":"13","author":"Yang","year":"2022","journal-title":"Protein Cell"},{"key":"10.1016\/j.ejca.2026.116731_bib26","doi-asserted-by":"crossref","first-page":"5405","DOI":"10.1038\/s41467-021-25662-9","article-title":"TRAPPC4 regulates the intracellular trafficking of PD-L1 and antitumor immunity","volume":"12","author":"Ren","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.ejca.2026.116731_bib27","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/s41416-025-02960-3","article-title":"Associations of mucinous differentiation and mucin expression with immune cell infiltration and prognosis in colorectal adenocarcinoma","volume":"132","author":"Elomaa","year":"2025","journal-title":"Br J Cancer"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804926005113?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804926005113?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T08:11:14Z","timestamp":1777623074000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804926005113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":27,"alternative-id":["S0959804926005113"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2026.116731","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From clusters to clinic: An 8-gene signature combined with mucinous component stratifies benefit of anti-CTLA-4 addition to anti-PD-1 in dMMR\/MSI-H metastatic colorectal cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2026.116731","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"116731"}}